The annual JP Morgan Healthcare Conference in San Francisco is set to draw thousands of professionals from the biopharma sector. While this major event facilitates acquisitions,...
Artificial intelligence (AI) is poised to transform the biopharmaceutical industry, with expectations that a company will soon announce the first AI-designed antibody entering clinical trials. The...
The first quarter of 2024 is shaping up to be significant for the biotech sector, with a range of pivotal events poised to influence stock performance....
The most-read essays from First Opinion in 2025 shed light on pressing issues within the life sciences sector, highlighting themes such as vaccines, health insurance challenges,...
Bruce Booth, a prominent figure in the biotech venture capital landscape, forecasts a significant increase in initial public offerings (IPOs) for 2026. This prediction comes after...
For many researchers in the United States, the year 2025 marks a significant turning point in the landscape of scientific funding. The Trump administration has dramatically...
